Sudeep Pharma

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0QPI01025
  • NSEID: SUDEEPPHRM
  • BSEID: 544619
INR
1,053.85
95.8 (10.0%)
BSENSE

Aug 10

BSE+NSE Vol: 9.47 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summary Full Price Action
 
calendar-icon
calendar-icon
stock-summary Sudeep Pharma- Today
Today's Price Stats stock-summary
BSE | Aug 10, 03:59 | BSE 544619
Factor
Value
Volume traded
71,254
Weighted Avg Price
INR 1,014.47
Face Value
1.00
Prev. Close
INR 958.05
Open Price
INR 995.15
Bid Price(Qty.)
INR 1,053.85 (42110)
Offer Price(Qty.)
INR 1,052.95 (8)
Today's Low/High
975.101,053.85
52 Wk Low
52 Wk High
0.000.00
Today's Price Summary (BSE) stock-summary
As of: 01:16 AM on 11-Aug
stock-summary

New 52 Week and All time High

Rs.1053.85 hit today

stock-summary

Performance Today

Outperformed Sector by 10.26%

stock-summary

Open Gap Up

Stock opened with a gain of 3.87% today

stock-summary

Day's High

Stock touched an intraday high of Rs 1053.85 (10%)

stock-summary

Weighted Average Price

More Volume traded close to Low Price

stock-summary

Moving Averages

Sudeep Pharma is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages

stock-summary

Falling Investor Participation

Delivery Vol of 1.47 lacs on 07 Aug has fallen by -38.39% against 5-day avg delivery vol

stock-summary

Liquidity

Based on 2% of 5 day average traded Value the stock is liquid enough for trade size of Rs 1.25 cr

Moving Averages stock-summary
BSE | Aug 11, 01:16AM | BSE 544619
Sudeep Pharma is trading higher than 5, 20, 50 day and 100 day moving averages
Factor
Value
5 Days
959.38
20 Days
883.04
50 Days
837.02
100 Days
739.99
200 Days
NA
Delivery Volumes stock-summary
Data as of: Aug 10, 03:59
Period
Avg Del Vol
Avg Del %
10-Aug-26
3.89 lacs
41.15
5 Day Avg
2.41 lacs
35.30
Trailing 1 Month Avg
1.42 lacs
41.25
Previous 1 Month Avg
1.67 lacs
49.32

Trailing 1 Month: 10-Jul-26 To 10-Aug-26

Previous 1 Month: 09-Jun-26 To 09-Jul-26

stock-summary

1 Month

Delivery volume fell by 15.29%

stock-summary

1 Day

Delivery volume increased by 61.37% over 5 day average

stock-summaryBulk Deals
Recent Bulk Deals
BUY
4-Aug-2026

Goldman Sachs Funds - Goldman Sachs India Equity Portfolio bought 11.76 lacs shares at INR 850 on NSE

SELL
4-Aug-2026

Nuvama Crossover Opportunities Fund - Series Iii sold 6.14 lacs shares at INR 850 on NSE

SELL
24-Jul-2026

Nuvama Crossover Opportunities Fund - Series Iii sold 10.6 lacs shares at INR 800 on NSE

SELL
24-Jul-2026

Nuvama Crossover Opportunities Fund - Series Iiia sold 9.4 lacs shares at INR 800 on NSE

BUY
24-Jul-2026

Sbi Mutual Fund bought 2 lacs shares at INR 800 on NSE

stock-summaryBlock Deals
Recent Block Deals
BUY
4-Aug-2026

Goldman Sachs Funds - Goldman Sachs India Equity Portfolio bought 11.76 lacs shares at INR 850 on NSE

SELL
4-Aug-2026

Nuvama Crossover Opportunities Fund - Series Iii sold 6.14 lacs shares at INR 850 on NSE

SELL
4-Aug-2026

Nuvama Crossover Opportunities Fund - Series Iiia sold 5.62 lacs shares at INR 850 on NSE

SELL
24-Jul-2026

Nuvama Crossover Opportunities Fund - Series Iii sold 10.6 lacs shares at INR 800 on NSE

SELL
24-Jul-2026

Nuvama Crossover Opportunities Fund - Series Iiia sold 9.4 lacs shares at INR 800 on NSE

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."